carboplatin,etoposide,atezolizumab,tiragolumab
merck,roche
['skyscraper-02', 'sclc', 'tecentriq', '$rhhby', '$mrk']
wow, $rhhby skyscraper-02 data (1l sclc) were spectacularly bad: tigit + tecentriq numerically worse on pfs than tecentriq (control did a bit better than in impower-133) #asco22 $mrk 
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.